control group:traditional chemotherapy

2 trials

Sponsors

PLA 309th Hospital, Department of Gynecologic Oncology,Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Conditions

non-small cell lung cancerovarian cancer

Phase 2

Neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced serous ovairan cancer: a randomized phase II trial

RecruitingChiCTR2000038173

Department of Gynecologic Oncology,Sun Yat-sen Memorial Hospital, Sun Yat-sen Universityovarian cancer

Start: 2020-10-08Updated: 2020-12-07

Unknown Phase

Therapeutic effect of CalliSperes microballoon bronchial artery chemoembolization on refractory non-small cell lung cancer with pleural effusionTherapeutic effect of CalliSperes microballoon bronchial artery chemoembolization on refractory non-small cell lung cancer with pleural effusion: a historical control study

Active, not recruitingChiCTR2000033063

PLA 309th Hospitalnon-small cell lung cancer

Start: 2019-06-01Updated: 2020-05-25

Related Papers

Heterogeneous cellular responses to hyperthermia support combined intraperitoneal hyperthermic immunotherapy for ovarian cancer mouse models

Science Translational Medicine2025-03-125 citations

152 Longitudinal single-cell RNA-seq of ovarian cancer delineates dynamic cellular changes upon hyperthermia

2024-03-01

Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial

BMJ Open2021-12-013 citations